Vienna, Austria – January 2025: Since its establishment in 2013, the UNODC Early Warning Advisory (EWA) on new psychoactive substances (NPS) regularly provides scientific information to Member States and
Read more
VIENNA, Austria – December 2024: The decision adopted by the Commission on Narcotic Drugs (CND) during its 67th Session, from 18 to 22 March 2024, to add 3-chloromethcathinone (3-CMC), Dipentylone and 2-fluorodeschloroketamine to
Read more
Vienna, Austria – November 2024: A series of new cannabinoids with structural similarities to cannabinoids that occur naturally in the
Read more
VIENNA, Austria – October 2024: In 2023, a total of 44 unique new psychoactive substances (NPS) have been reported for the first
Read more
VIENNA, Austria – October 2024: A total of 1,250 unique new psychoactive substances (NPS) have been reported to the UNODC Early
Read more
GENEVA, Switzerland – September 2024: The World Health Organization (WHO) evaluates the dependence-producing properties and potential harm to health of psychoactive
Read more
VIENNA, Austria – August 2024: Following the detection of large-scale clandestine ketamine laboratories in recent years, several countries and territories
Read more
VIENNA, Austria – July 2024: The UNODC Current NPS Threats Vol. VII (July 2024) presents recent analysis from the UNODC Early
Read more
VIENNA, Austria – June 2024: The challenge of New Psychoactive Substances – A technical update 2024 providesupdate information on the
Read more
VIENNA, Austria – June 2024: The decision adopted by the Commission on Narcotic Drugs (CND) during its 67th regular session from 18 to 22
Read more